ora™ is the world’s first non-invasive test that determines the so-called Window of Implantation (WOI) – the period when the endometrium is ready to receive an embryo.
The test is performed using a standard blood sample, so the patient does not need to undergo an uncomfortable biopsy.
The test analyzes nearly 300 microRNA biomarkers in blood plasma, which are associated with more than 1,000 genes linked to endometrial receptivity.
Based on their expression, the test determines whether the endometrium is:
receptive
pre-receptive
post-receptive
accurately time embryo transfer during an IVF cycle
improve synchronization between the endometrium and the embryo
reduce the number of failed implantation cycles
women with recurrent implantation failure or miscarriages
patients over 35 years of age
women with high or low BMI
couples with limited numbers of high-quality embryos
Non-invasive method – blood draw instead of biopsy
High accuracy – over 95% success rate in determining WOI
Single test cycle – with the option of two blood draws (e.g., on days 4 and 5 after starting progesterone)
Fast turnaround – results available within a few days after analysis
Suitable for both natural and hormone-controlled cycles
For more information, please contact us by e-mail: reprodukce@pentagen.cz
